As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (NASDAQ:GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements.

GE HealthCare continues to invest in advanced MR technology with its next-generation SIGNATM MR systems and research tools designed to help academic and clinical research programs move faster, work more collaboratively, and push the boundaries of discovery. By combining high-performance hardware with advanced software and deep learning–based techniques, these innovations are intended to reduce scanning and examination times, improve image quality, and enable more consistent data across sites and studies.